Have you finally decided to explore treatment plans for weight loss or erectile dysfunction? Are you finding that ...

New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people ...

The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...

A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes med ...

Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...

The use of GLP-1 RAs is associated with the risk for retained gastric contents and inadequate bowel preparation during endoscopic procedures.

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...

U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to ...

The New York Times: Ozempic's Next Magic Trick: Treating Drug Addiction Could these medications — collectively known as GLP-1 receptor agonists — also fight America’s most difficult drug ...

The thirty-something couple compares their experience of starting their first restaurant to raising children; they were fresh ...

Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...